BRIEF published on 04/29/2026 at 13:44, 13 days 7 hours ago Croissance impressionnante des ventes de UZEDY® au T1 2026 Schizophrénie Medincell Teva Pharmaceuticals UZEDY® Ventes T1 2026
BRIEF published on 04/29/2026 at 13:44, 13 days 7 hours ago UZEDY® Q1 2026 Sales Surge by 62% FDA Approvals Olanzapine LAI UZEDY® Sales Teva Partnership Medincell Growth
BRIEF published on 04/29/2026 at 13:44, 13 days 7 hours ago Les ventes d'UZEDY® au premier trimestre 2026 devraient bondir de 62 %. Olanzapine LAI Ventes UZEDY® Partenariat Avec Teva Approbations De La FDA Croissance De Medincell
BRIEF published on 04/29/2026 at 13:44, 13 days 7 hours ago Impressive sales growth for UZEDY® in Q1 2026 Schizophrenia Medincell Teva Pharmaceuticals UZEDY® Q1 2026 Sales
PRESS RELEASE published on 04/29/2026 at 13:39, 13 days 7 hours ago Inside Information / Other news releases Medincell's partner Teva Pharmaceuticals reports UZEDY Q1 2026 net sales of $63M, a 62% increase year-on-year. Olanzapine LAI NDA accepted by FDA. Medincell focuses on long-acting injectable treatments across various therapeutic areas Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY Long-acting Injectable
PRESS RELEASE published on 04/29/2026 at 13:39, 13 days 7 hours ago Informations privilégiées / Autres communiqués Medincell annonce une forte croissance des ventes de UZEDY aux Etats-Unis, une formulation injectable approuvée par la FDA pour la schizophrénie et le trouble bipolaire. De nouvelles avancées pour l'olanzapine LAI sont également en cours FDA Schizophrénie Medincell Teva UZEDY
BRIEF published on 04/20/2026 at 11:18, 22 days 10 hours ago Franchissement de seuil par BNP Paribas Développement chez MEDINCELL Euronext Paris Droits De Vote Franchissement De Seuil BNP Paribas Medincell
BRIEF published on 04/20/2026 at 11:18, 22 days 10 hours ago BNP Paribas Développement crosses a threshold at MEDICELL Euronext Paris Voting Rights BNP Paribas Threshold Crossing MEDICELL
PRESS RELEASE published on 04/20/2026 at 11:13, 22 days 10 hours ago Franchissement de seuil Déclaration de franchissement de seuil par BNP Paribas Développement concernant MEDINCELL sur Euronext Paris Euronext Paris Droits De Vote Franchissement De Seuil Medincell BNP Paribas Développement
BRIEF published on 04/02/2026 at 19:05, 1 month 10 days ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
Published on 05/12/2026 at 14:30, 7 hours 7 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 14:30, 7 hours 7 minutes ago ACCESS Newswire Reports First Quarter 2026 Results
Published on 05/12/2026 at 13:50, 7 hours 47 minutes ago Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB
Published on 05/12/2026 at 13:30, 8 hours 7 minutes ago Silver X Mining Begins Trading on OTCQX, Expanding Access to U.S. Investors
Published on 05/12/2026 at 13:30, 8 hours 7 minutes ago Electric Metals Launches Preliminary Economic Assessment for North Star Manganese Project Downstream HPMSM and EMM Processing Facilities
Published on 05/12/2026 at 20:21, 1 hour 15 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 2 hours 1 minute ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 2 hours 2 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:46, 2 hours 50 minutes ago LION E-Mobility Reports Q1 Results and Confirms Fiscal 2026 Outlook
Published on 05/12/2026 at 18:45, 2 hours 52 minutes ago Antitrust authority approval granted for the acquisition of a portfolio of rental units in Poland
Published on 05/12/2026 at 18:15, 3 hours 22 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 3 hours 22 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 3 hours 27 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 3 hours 27 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 3 hours 47 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
